Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): a protocol for a participant and assessor-blinded randomised controlled trial
Joanne L Kemp, Richard TR Johnston, Sally L Coburn, Denise M Jones, Anthony G Schache, Benjamin F Mentiplay, Matthew G King, Mark J Scholes, Danilo De Oliveira Silva, Anne Smith, Steven M McPhail, Kay M Crossley
BMJ OPEN | BMJ PUBLISHING GROUP | Published : 2021
INTRODUCTION: This double-blind, randomised controlled trial (RCT) aims to estimate the effect of a physiotherapist-led intervention with targeted strengthening compared with a physiotherapist-led intervention with standardised stretching, on hip-related quality of life (QOL) or perceived improvement at 6 months in people with femoroacetabular impingement (FAI) syndrome. We hypothesise that at 6 months, targeted strengthening physiotherapist-led treatment will be associated with greater improvements in hip-related QOL or greater patient-perceived global improvement when compared with standardised stretching physiotherapist-led treatment. METHODS AND ANALYSIS: We will recruit 164 participants..View full abstract
Awarded by National Health and Medical Research Council of Australia
JLK and SMM are funded by the National Health and Medical Research Council of Australia (JLK NHMRC ECF 1119971 and SMM NHMRC fellowship 1161138). Arthritis Australia contributed to the funding of this study.